REVIEW

Matrix metalloproteinases in diabesity

Lokesh Bhatt , Veeranjaneyulu Addepalli

Lokesh Bhatt
Department of Pharmacology, SPP School of Pharmacy and Technology Management, NMIMS University, Vile Parle (W), Mumbai, 400 056, India. Email: addepalliv@gmail.com

Veeranjaneyulu Addepalli
Department of Pharmacology, SPP School of Pharmacy and Technology Management, NMIMS University, Vile Parle (W), Mumbai, 400 056, India
Online First: March 15, 2015 | Cite this Article
Bhatt, L., Addepalli, V. 2015. Matrix metalloproteinases in diabesity. Diabesity 1(2): 18-20. DOI:10.15562/diabesity.2015.13


Diabesity, the Obesity-Diabetes Epidemic, is one of the major global health problems. Complications associated with it resulted in serious complications and need urgent attention for new therapeutic approaches. In recent years, evidence supporting role of Matrix metalloproteinases and their inhibitors in development of diabesity associated complications are increased. Due to their role in diabesity associated complications they may be potential therapeutic targets.
No Supplementary Material available for this article.
Article Views      : 27
PDF Downloads : 7